Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

Glaxosmithkline Pharmaceuticals Ltd share ... DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt.

Annual ResultsBIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS 14.03.2025 / 07:00 CET/CESTBasel, Switzerland. March 14, 2025, 7am CETBioVersys AG (SIX: BIOV), ...

Hydration Boosters Market. The global hydration boosters market is poised for substantial growth, with a projected valuation ...

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling - not so ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Pursuant to Articles 10-14 of the Articles of Association, the shareholders of Bavarian Nordic A/S are hereby convened to the Annual General Meeting to be held on Wednesday, 9 April 2025, at 4 PM CEST ...

In 1950, the company synthesised the central nervous system treatment, chlorpromazine, which it later sold to GlaxoSmithKline ... company launched a dedicated website called Sanofi-Aventis TV ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...